{
	"File": {
		"__typename": "FileMatch",
		"repository": {
			"name": "github.com/Chinlinlee/Burni"
		},
		"file": {
			"name": "swagger.json",
			"size": 0,
			"path": "docs/apidoc/redoc/MedicinalProductIndication/swagger.json",
			"byteSize": 39614,
			"content": "{\"openapi\":\"3.0.0\",\"servers\":[{\"url\":\"https://dev.burni.xn--7-c56d.com/\"}],\"info\":{\"title\":\"Burni API documentation\",\"version\":\"v2.1.0\",\"description\":\"Documentation for the REST API\"},\"paths\":{\"/fhir/MedicinalProductIndication\":{\"post\":{\"operationId\":\"createMedicinalProductIndication\",\"tags\":[\"MedicinalProductIndication\"],\"summary\":\"create MedicinalProductIndication resource.\",\"parameters\":[],\"requestBody\":{\"content\":{\"application/fhir+json\":{\"schema\":{\"$ref\":\"#/components/schemas/createMedicinalProductIndication\"},\"examples\":{\"json-example\":{\"value\":{\"resourceType\":\"MedicinalProductIndication\",\"id\":\"example\",\"text\":{\"status\":\"generated\",\"div\":\"\u003cdiv xmlns=\\\"http://www.w3.org/1999/xhtml\\\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative with Details\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eid\u003c/b\u003e: example\u003c/p\u003e\u003cp\u003e\u003cb\u003ediseaseSymptomProcedure\u003c/b\u003e: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). \u003cspan\u003e(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecomorbidity\u003c/b\u003e: Hipsurgery \u003cspan\u003e(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eintendedEffect\u003c/b\u003e: PRYLX \u003cspan\u003e(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003epopulation\u003c/b\u003e: \u003c/p\u003e\u003c/div\u003e\"},\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":18,\"unit\":\"a\"}}}],\"meta\":{\"tag\":[{\"system\":\"http://terminology.hl7.org/CodeSystem/v3-ActReason\",\"code\":\"HTEST\",\"display\":\"test health data\"}]}}}}},\"application/fhir+xml\":{\"schema\":{\"$ref\":\"#/components/schemas/createMedicinalProductIndication\",\"xml\":{\"name\":\"MedicinalProductIndication\"}},\"examples\":{\"xml-example\":{\"value\":\"\\n\u003c?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?\u003e\u003cMedicinalProductIndication xmlns=\\\"http://hl7.org/fhir\\\"\u003e\u003cid value=\\\"example\\\"/\u003e\u003cmeta\u003e\u003ctag\u003e\u003csystem value=\\\"http://terminology.hl7.org/CodeSystem/v3-ActReason\\\"/\u003e\u003ccode value=\\\"HTEST\\\"/\u003e\u003cdisplay value=\\\"test health data\\\"/\u003e\u003c/tag\u003e\u003c/meta\u003e\u003ctext\u003e\u003cstatus value=\\\"generated\\\"/\u003e\u003cdiv xmlns=\\\"http://www.w3.org/1999/xhtml\\\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative with Details\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eid\u003c/b\u003e: example\u003c/p\u003e\u003cp\u003e\u003cb\u003ediseaseSymptomProcedure\u003c/b\u003e: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). \u003cspan\u003e(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecomorbidity\u003c/b\u003e: Hipsurgery \u003cspan\u003e(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eintendedEffect\u003c/b\u003e: PRYLX \u003cspan\u003e(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003epopulation\u003c/b\u003e: \u003c/p\u003e\u003c/div\u003e\u003c/text\u003e\u003cdiseaseSymptomProcedure\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\"/\u003e\u003ccode value=\\\"Venousthromboembolismprophylaxis\\\"/\u003e\u003c/coding\u003e\u003ctext value=\\\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\\\"/\u003e\u003c/diseaseSymptomProcedure\u003e\u003ccomorbidity\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/comorbidity\\\"/\u003e\u003ccode value=\\\"Hipsurgery\\\"/\u003e\u003c/coding\u003e\u003c/comorbidity\u003e\u003cintendedEffect\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/intendedeffect\\\"/\u003e\u003ccode value=\\\"PRYLX\\\"/\u003e\u003c/coding\u003e\u003c/intendedEffect\u003e\u003cpopulation\u003e\u003cageRange\u003e\u003clow\u003e\u003cvalue value=\\\"18\\\"/\u003e\u003cunit value=\\\"a\\\"/\u003e\u003c/low\u003e\u003c/ageRange\u003e\u003c/population\u003e\u003c/MedicinalProductIndication\u003e\"}}}}},\"description\":\"create MedicinalProductIndication resource.\",\"responses\":{\"200\":{\"description\":\"successful operation\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"json-example\":{\"value\":{\"resourceType\":\"MedicinalProductIndication\",\"id\":\"61904286-cdc0-4700-9c7a-d5f3d9bad827\",\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":18,\"unit\":\"a\"}}}],\"meta\":{\"tag\":[{\"system\":\"http://terminology.hl7.org/CodeSystem/v3-ActReason\",\"code\":\"HTEST\",\"display\":\"test health data\"}],\"versionId\":\"1\",\"lastUpdated\":\"2022-02-13T22:30:17.924+08:00\"}}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"MedicinalProductIndication\"}},\"examples\":{\"xml-example\":{\"value\":\"\u003c?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?\u003e\u003cMedicinalProductIndication xmlns=\\\"http://hl7.org/fhir\\\"\u003e\u003cid value=\\\"80efee93-8d5a-4f98-aba7-ed1a8e88e0fc\\\"/\u003e\u003cmeta\u003e\u003cversionId value=\\\"1\\\"/\u003e\u003clastUpdated value=\\\"2022-02-17T17:34:54.818+08:00\\\"/\u003e\u003ctag\u003e\u003csystem value=\\\"http://terminology.hl7.org/CodeSystem/v3-ActReason\\\"/\u003e\u003ccode value=\\\"HTEST\\\"/\u003e\u003cdisplay value=\\\"test health data\\\"/\u003e\u003c/tag\u003e\u003c/meta\u003e\u003cdiseaseSymptomProcedure\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\"/\u003e\u003ccode value=\\\"Venousthromboembolismprophylaxis\\\"/\u003e\u003c/coding\u003e\u003ctext value=\\\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\\\"/\u003e\u003c/diseaseSymptomProcedure\u003e\u003ccomorbidity\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/comorbidity\\\"/\u003e\u003ccode value=\\\"Hipsurgery\\\"/\u003e\u003c/coding\u003e\u003c/comorbidity\u003e\u003cintendedEffect\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/intendedeffect\\\"/\u003e\u003ccode value=\\\"PRYLX\\\"/\u003e\u003c/coding\u003e\u003c/intendedEffect\u003e\u003cpopulation\u003e\u003cageRange\u003e\u003clow\u003e\u003cvalue value=\\\"18\\\"/\u003e\u003cunit value=\\\"a\\\"/\u003e\u003c/low\u003e\u003c/ageRange\u003e\u003c/population\u003e\u003c/MedicinalProductIndication\u003e\"}}}}},\"400\":{\"description\":\"error\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"Bad-Request-Response\":{\"value\":{\"resourceType\":\"OperationOutcome\",\"issue\":[{\"severity\":\"error\",\"code\":\"exception\",\"diagnostics\":\"validation error, path `resourceType` is required\"}]}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"OperationOutcome\"}},\"examples\":{\"Bad-Request-Response\":{\"value\":\"\\n\u003cOperationOutcome xmlns='http://hl7.org/fhir'\u003e\\n\u003cissue\u003e\\n    \u003cseverity value='error'/\u003e\\n    \u003ccode value='exception'/\u003e\\n    \u003cdiagnostics value='validation error, path `resourceType` is required'/\u003e\\n\u003c/issue\u003e\\n\u003c/OperationOutcome\u003e\"}}}}}},\"x-codeSamples\":[{\"lang\":\"Shell\",\"source\":\"#example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\\ncurl --location --request POST 'http://burni.example.com/fhir/MedicinalProductIndication \\\\' \\n--header 'Content-Type: application/fhir+json' \\\\\\n--data-raw '{\\\"resourceType\\\":\\\"MedicinalProductIndication\\\",\\\"id\\\":\\\"61904286-cdc0-4700-9c7a-d5f3d9bad827\\\",\\\"diseaseSymptomProcedure\\\":{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\",\\\"code\\\":\\\"Venousthromboembolismprophylaxis\\\"}],\\\"text\\\":\\\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\\\\\nor knee replacement surgery.\\\\\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\\\"},\\\"comorbidity\\\":[{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/comorbidity\\\",\\\"code\\\":\\\"Hipsurgery\\\"}]}],\\\"intendedEffect\\\":{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/intendedeffect\\\",\\\"code\\\":\\\"PRYLX\\\"}]},\\\"population\\\":[{\\\"ageRange\\\":{\\\"low\\\":{\\\"value\\\":18,\\\"unit\\\":\\\"a\\\"}}}],\\\"meta\\\":{\\\"tag\\\":[{\\\"system\\\":\\\"http://terminology.hl7.org/CodeSystem/v3-ActReason\\\",\\\"code\\\":\\\"HTEST\\\",\\\"display\\\":\\\"test health data\\\"}],\\\"versionId\\\":\\\"1\\\",\\\"lastUpdated\\\":\\\"2022-02-13T22:30:17.924+08:00\\\"}}'\",\"label\":\"cURL\"},{\"lang\":\"JavaScript\",\"source\":\" //example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\\nconst axios = require('axios');\\nconst data = {\\\"resourceType\\\":\\\"MedicinalProductIndication\\\",\\\"id\\\":\\\"61904286-cdc0-4700-9c7a-d5f3d9bad827\\\",\\\"diseaseSymptomProcedure\\\":{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\",\\\"code\\\":\\\"Venousthromboembolismprophylaxis\\\"}],\\\"text\\\":\\\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\\\\\nor knee replacement surgery.\\\\\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\\\"},\\\"comorbidity\\\":[{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/comorbidity\\\",\\\"code\\\":\\\"Hipsurgery\\\"}]}],\\\"intendedEffect\\\":{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/intendedeffect\\\",\\\"code\\\":\\\"PRYLX\\\"}]},\\\"population\\\":[{\\\"ageRange\\\":{\\\"low\\\":{\\\"value\\\":18,\\\"unit\\\":\\\"a\\\"}}}],\\\"meta\\\":{\\\"tag\\\":[{\\\"system\\\":\\\"http://terminology.hl7.org/CodeSystem/v3-ActReason\\\",\\\"code\\\":\\\"HTEST\\\",\\\"display\\\":\\\"test health data\\\"}],\\\"versionId\\\":\\\"1\\\",\\\"lastUpdated\\\":\\\"2022-02-13T22:30:17.924+08:00\\\"}}\\nconst config = {\\n    method: 'post',\\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication',\\n    headers: { \\n        'Content-Type': 'application/fhir+json'\\n    },\\n    data: data\\n};\\n\\naxios(config)\\n.then(function (response) {\\n    console.log(JSON.stringify(response.data));\\n})\\n.catch(function (error) {\\n    console.log(error);\\n});\",\"label\":\"javascript Axios\"}]}},\"/fhir/MedicinalProductIndication/{id}\":{\"delete\":{\"operationId\":\"deleteMedicinalProductIndication\",\"tags\":[\"MedicinalProductIndication\"],\"summary\":\"delete MedicinalProductIndication resource by id.\",\"parameters\":[{\"name\":\"id\",\"in\":\"path\",\"required\":true,\"schema\":{\"type\":\"string\"},\"description\":\"Resource ID in server\"}],\"responses\":{\"200\":{\"description\":\"successful operation\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"Success-Response\":{\"value\":{\"resourceType\":\"OperationOutcome\",\"issue\":[{\"severity\":\"information\",\"code\":\"informational\",\"diagnostics\":\"delete MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827 successfully\"}]}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"OperationOutcome\"}},\"examples\":{\"Success-Response-XML\":{\"value\":\"\u003cOperationOutcome xmlns='http://hl7.org/fhir'\u003e\\n    \u003cissue\u003e\\n    \u003cseverity value='information'/\u003e\\n    \u003ccode value='informational'/\u003e\\n    \u003cdiagnostics value='delete MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827 successfully'/\u003e\\n    \u003c/issue\u003e\\n\u003c/OperationOutcome\u003e\"}}}}},\"404\":{\"description\":\"error\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"Not-Found-Response\":{\"value\":{\"resourceType\":\"OperationOutcome\",\"issue\":[{\"severity\":\"error\",\"code\":\"exception\",\"diagnostics\":\"The id-\u003e61904286-cdc0-4700-9c7a-d5f3d9bad827 not found in MedicinalProductIndication resource\"}]}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"OperationOutcome\"}},\"examples\":{\"Not-Found-Response-XML\":{\"value\":\"\u003cOperationOutcome xmlns='http://hl7.org/fhir'\u003e\\n    \u003cissue\u003e\\n    \u003cseverity value='error'/\u003e\\n    \u003ccode value='not-found'/\u003e\\n    \u003cdiagnostics value='The id-\u0026gt;61904286-cdc0-4700-9c7a-d5f3d9bad827  not found in MedicinalProductIndication resource'/\u003e\\n    \u003c/issue\u003e\\n\u003c/OperationOutcome\u003e\"}}}}}},\"x-codeSamples\":[{\"lang\":\"Shell\",\"source\":\"#example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\\ncurl --location --request DELETE 'http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'\",\"label\":\"cURL\"},{\"lang\":\"JavaScript\",\"source\":\" //example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\\nconst axios = require('axios');\\nconst config = {\\n    method: 'delete',\\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'\\n};\\n\\naxios(config)\\n.then(function (response) {\\n    console.log(JSON.stringify(response.data));\\n})\\n.catch(function (error) {\\n    console.log(error);\\n});\",\"label\":\"javascript Axios\"}]},\"get\":{\"operationId\":\"readMedicinalProductIndication\",\"tags\":[\"MedicinalProductIndication\"],\"summary\":\"read MedicinalProductIndication resource by id.\",\"parameters\":[{\"name\":\"id\",\"in\":\"path\",\"required\":true,\"schema\":{\"type\":\"string\"},\"description\":\"Resource ID in server\"}],\"responses\":{\"200\":{\"description\":\"successful operation\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"Success-Response\":{\"value\":{\"resourceType\":\"MedicinalProductIndication\",\"id\":\"61904286-cdc0-4700-9c7a-d5f3d9bad827\",\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":18,\"unit\":\"a\"}}}],\"meta\":{\"tag\":[{\"system\":\"http://terminology.hl7.org/CodeSystem/v3-ActReason\",\"code\":\"HTEST\",\"display\":\"test health data\"}],\"versionId\":\"1\",\"lastUpdated\":\"2022-02-13T22:30:17.924+08:00\"}}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"MedicinalProductIndication\"}},\"examples\":{\"Success-Response-XML\":{\"value\":\"\u003c?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?\u003e\u003cMedicinalProductIndication xmlns=\\\"http://hl7.org/fhir\\\"\u003e\u003cid value=\\\"80efee93-8d5a-4f98-aba7-ed1a8e88e0fc\\\"/\u003e\u003cmeta\u003e\u003cversionId value=\\\"1\\\"/\u003e\u003clastUpdated value=\\\"2022-02-17T17:34:54.818+08:00\\\"/\u003e\u003ctag\u003e\u003csystem value=\\\"http://terminology.hl7.org/CodeSystem/v3-ActReason\\\"/\u003e\u003ccode value=\\\"HTEST\\\"/\u003e\u003cdisplay value=\\\"test health data\\\"/\u003e\u003c/tag\u003e\u003c/meta\u003e\u003cdiseaseSymptomProcedure\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\"/\u003e\u003ccode value=\\\"Venousthromboembolismprophylaxis\\\"/\u003e\u003c/coding\u003e\u003ctext value=\\\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\\\"/\u003e\u003c/diseaseSymptomProcedure\u003e\u003ccomorbidity\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/comorbidity\\\"/\u003e\u003ccode value=\\\"Hipsurgery\\\"/\u003e\u003c/coding\u003e\u003c/comorbidity\u003e\u003cintendedEffect\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/intendedeffect\\\"/\u003e\u003ccode value=\\\"PRYLX\\\"/\u003e\u003c/coding\u003e\u003c/intendedEffect\u003e\u003cpopulation\u003e\u003cageRange\u003e\u003clow\u003e\u003cvalue value=\\\"18\\\"/\u003e\u003cunit value=\\\"a\\\"/\u003e\u003c/low\u003e\u003c/ageRange\u003e\u003c/population\u003e\u003c/MedicinalProductIndication\u003e\"}}}}},\"404\":{\"description\":\"error\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"Not-Found-Response\":{\"value\":{\"resourceType\":\"OperationOutcome\",\"issue\":[{\"severity\":\"error\",\"code\":\"exception\",\"diagnostics\":\"not found MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827\"}]}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"OperationOutcome\"}},\"examples\":{\"Not-Found-Response-XML\":{\"value\":\"\u003cOperationOutcome xmlns='http://hl7.org/fhir'\u003e\\n\u003cissue\u003e\\n    \u003cseverity value='error'/\u003e\\n    \u003ccode value='exception'/\u003e\\n    \u003cdiagnostics value='not found MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'/\u003e\\n\u003c/issue\u003e\\n\u003c/OperationOutcome\u003e\"}}}}}},\"x-codeSamples\":[{\"lang\":\"Shell\",\"source\":\"#example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\\ncurl --location --request GET 'http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'\",\"label\":\"cURL\"},{\"lang\":\"JavaScript\",\"source\":\" //example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\\nconst axios = require('axios');\\nconst config = {\\n    method: 'get',\\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'\\n};\\n\\naxios(config)\\n.then(function (response) {\\n    console.log(JSON.stringify(response.data));\\n})\\n.catch(function (error) {\\n    console.log(error);\\n});\",\"label\":\"javascript Axios\"}]},\"put\":{\"operationId\":\"updateMedicinalProductIndication\",\"tags\":[\"MedicinalProductIndication\"],\"summary\":\"update MedicinalProductIndication resource.\",\"parameters\":[{\"name\":\"id\",\"in\":\"path\",\"required\":true,\"schema\":{\"type\":\"string\"},\"description\":\"Resource ID that you want to update\"}],\"requestBody\":{\"content\":{\"application/fhir+json\":{\"schema\":{\"$ref\":\"#/components/schemas/updateMedicinalProductIndication\"},\"examples\":{\"json-example\":{\"value\":{\"resourceType\":\"MedicinalProductIndication\",\"id\":\"example\",\"text\":{\"status\":\"generated\",\"div\":\"\u003cdiv xmlns=\\\"http://www.w3.org/1999/xhtml\\\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative with Details\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eid\u003c/b\u003e: example\u003c/p\u003e\u003cp\u003e\u003cb\u003ediseaseSymptomProcedure\u003c/b\u003e: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). \u003cspan\u003e(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecomorbidity\u003c/b\u003e: Hipsurgery \u003cspan\u003e(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eintendedEffect\u003c/b\u003e: PRYLX \u003cspan\u003e(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003epopulation\u003c/b\u003e: \u003c/p\u003e\u003c/div\u003e\"},\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"pq7TgegGiaq\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":57693,\"unit\":\"a\"}}}],\"meta\":{\"tag\":[{\"system\":\"http://terminology.hl7.org/CodeSystem/v3-ActReason\",\"code\":\"HTEST\",\"display\":\"IamoeA459qC2O\"}]}}}}},\"application/fhir+xml\":{\"schema\":{\"$ref\":\"#/components/schemas/updateMedicinalProductIndication\",\"xml\":{\"name\":\"MedicinalProductIndication\"}},\"examples\":{\"xml-example\":{\"value\":\"\\n\u003c?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?\u003e\u003cMedicinalProductIndication xmlns=\\\"http://hl7.org/fhir\\\"\u003e\u003cid value=\\\"example\\\"/\u003e\u003cmeta\u003e\u003ctag\u003e\u003csystem value=\\\"http://terminology.hl7.org/CodeSystem/v3-ActReason\\\"/\u003e\u003ccode value=\\\"HTEST\\\"/\u003e\u003cdisplay value=\\\"IamoeA459qC2O\\\"/\u003e\u003c/tag\u003e\u003c/meta\u003e\u003ctext\u003e\u003cstatus value=\\\"generated\\\"/\u003e\u003cdiv xmlns=\\\"http://www.w3.org/1999/xhtml\\\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative with Details\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eid\u003c/b\u003e: example\u003c/p\u003e\u003cp\u003e\u003cb\u003ediseaseSymptomProcedure\u003c/b\u003e: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). \u003cspan\u003e(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecomorbidity\u003c/b\u003e: Hipsurgery \u003cspan\u003e(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eintendedEffect\u003c/b\u003e: PRYLX \u003cspan\u003e(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003epopulation\u003c/b\u003e: \u003c/p\u003e\u003c/div\u003e\u003c/text\u003e\u003cdiseaseSymptomProcedure\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\"/\u003e\u003ccode value=\\\"Venousthromboembolismprophylaxis\\\"/\u003e\u003c/coding\u003e\u003ctext value=\\\"pq7TgegGiaq\\\"/\u003e\u003c/diseaseSymptomProcedure\u003e\u003ccomorbidity\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/comorbidity\\\"/\u003e\u003ccode value=\\\"Hipsurgery\\\"/\u003e\u003c/coding\u003e\u003c/comorbidity\u003e\u003cintendedEffect\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/intendedeffect\\\"/\u003e\u003ccode value=\\\"PRYLX\\\"/\u003e\u003c/coding\u003e\u003c/intendedEffect\u003e\u003cpopulation\u003e\u003cageRange\u003e\u003clow\u003e\u003cvalue value=\\\"57693\\\"/\u003e\u003cunit value=\\\"a\\\"/\u003e\u003c/low\u003e\u003c/ageRange\u003e\u003c/population\u003e\u003c/MedicinalProductIndication\u003e\"}}}}},\"description\":\"update MedicinalProductIndication resource.\",\"responses\":{\"200\":{\"description\":\"successful operation\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"json-example\":{\"value\":{\"resourceType\":\"MedicinalProductIndication\",\"id\":\"MedicinalProductIndication-example\",\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"pq7TgegGiaq\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":57693,\"unit\":\"a\"}}}],\"meta\":{\"versionId\":\"20\",\"lastUpdated\":\"2022-02-17T23:28:25.651+08:00\"}}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"MedicinalProductIndication\"}},\"examples\":{\"xml-example\":{\"value\":\"\u003c?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?\u003e\u003cMedicinalProductIndication xmlns=\\\"http://hl7.org/fhir\\\"\u003e\u003cid value=\\\"MedicinalProductIndication-example\\\"/\u003e\u003cmeta\u003e\u003cversionId value=\\\"22\\\"/\u003e\u003clastUpdated value=\\\"2022-02-18T00:39:38.858+08:00\\\"/\u003e\u003c/meta\u003e\u003cdiseaseSymptomProcedure\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\"/\u003e\u003ccode value=\\\"Venousthromboembolismprophylaxis\\\"/\u003e\u003c/coding\u003e\u003ctext value=\\\"pq7TgegGiaq\\\"/\u003e\u003c/diseaseSymptomProcedure\u003e\u003ccomorbidity\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/comorbidity\\\"/\u003e\u003ccode value=\\\"Hipsurgery\\\"/\u003e\u003c/coding\u003e\u003c/comorbidity\u003e\u003cintendedEffect\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/intendedeffect\\\"/\u003e\u003ccode value=\\\"PRYLX\\\"/\u003e\u003c/coding\u003e\u003c/intendedEffect\u003e\u003cpopulation\u003e\u003cageRange\u003e\u003clow\u003e\u003cvalue value=\\\"57693\\\"/\u003e\u003cunit value=\\\"a\\\"/\u003e\u003c/low\u003e\u003c/ageRange\u003e\u003c/population\u003e\u003c/MedicinalProductIndication\u003e\"}}}}},\"400\":{\"description\":\"error\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"Bad-Request-Response\":{\"value\":{\"resourceType\":\"OperationOutcome\",\"issue\":[{\"severity\":\"error\",\"code\":\"exception\",\"diagnostics\":\"validation error, path `resourceType` is required\"}]}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"OperationOutcome\"}},\"examples\":{\"Bad-Request-Response\":{\"value\":\"\\n\u003cOperationOutcome xmlns='http://hl7.org/fhir'\u003e\\n\u003cissue\u003e\\n    \u003cseverity value='error'/\u003e\\n    \u003ccode value='exception'/\u003e\\n    \u003cdiagnostics value='validation error, path `resourceType` is required'/\u003e\\n\u003c/issue\u003e\\n\u003c/OperationOutcome\u003e\"}}}}}},\"x-codeSamples\":[{\"lang\":\"Shell\",\"source\":\"#example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\\ncurl --location --request PUT 'http://burni.example.com/fhir/MedicinalProductIndication/MedicinalProductIndication-example \\\\' \\n--header 'Content-Type: application/fhir+json' \\\\\\n--data-raw '{\\\"resourceType\\\":\\\"MedicinalProductIndication\\\",\\\"id\\\":\\\"example\\\",\\\"text\\\":{\\\"status\\\":\\\"generated\\\",\\\"div\\\":\\\"\u003cdiv xmlns=\\\\\\\"http://www.w3.org/1999/xhtml\\\\\\\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative with Details\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eid\u003c/b\u003e: example\u003c/p\u003e\u003cp\u003e\u003cb\u003ediseaseSymptomProcedure\u003c/b\u003e: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\\\\\nor knee replacement surgery.\\\\\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). \u003cspan\u003e(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecomorbidity\u003c/b\u003e: Hipsurgery \u003cspan\u003e(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eintendedEffect\u003c/b\u003e: PRYLX \u003cspan\u003e(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003epopulation\u003c/b\u003e: \u003c/p\u003e\u003c/div\u003e\\\"},\\\"diseaseSymptomProcedure\\\":{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\",\\\"code\\\":\\\"Venousthromboembolismprophylaxis\\\"}],\\\"text\\\":\\\"pq7TgegGiaq\\\"},\\\"comorbidity\\\":[{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/comorbidity\\\",\\\"code\\\":\\\"Hipsurgery\\\"}]}],\\\"intendedEffect\\\":{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/intendedeffect\\\",\\\"code\\\":\\\"PRYLX\\\"}]},\\\"population\\\":[{\\\"ageRange\\\":{\\\"low\\\":{\\\"value\\\":57693,\\\"unit\\\":\\\"a\\\"}}}],\\\"meta\\\":{\\\"tag\\\":[{\\\"system\\\":\\\"http://terminology.hl7.org/CodeSystem/v3-ActReason\\\",\\\"code\\\":\\\"HTEST\\\",\\\"display\\\":\\\"IamoeA459qC2O\\\"}]}}'\",\"label\":\"cURL\"},{\"lang\":\"JavaScript\",\"source\":\" //example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\\nconst axios = require('axios');\\nconst data = {\\\"resourceType\\\":\\\"MedicinalProductIndication\\\",\\\"id\\\":\\\"MedicinalProductIndication-example\\\",\\\"diseaseSymptomProcedure\\\":{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\",\\\"code\\\":\\\"Venousthromboembolismprophylaxis\\\"}],\\\"text\\\":\\\"pq7TgegGiaq\\\"},\\\"comorbidity\\\":[{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/comorbidity\\\",\\\"code\\\":\\\"Hipsurgery\\\"}]}],\\\"intendedEffect\\\":{\\\"coding\\\":[{\\\"system\\\":\\\"http://ema.europa.eu/example/intendedeffect\\\",\\\"code\\\":\\\"PRYLX\\\"}]},\\\"population\\\":[{\\\"ageRange\\\":{\\\"low\\\":{\\\"value\\\":57693,\\\"unit\\\":\\\"a\\\"}}}],\\\"meta\\\":{\\\"versionId\\\":\\\"20\\\",\\\"lastUpdated\\\":\\\"2022-02-17T23:28:25.651+08:00\\\"}}\\nconst config = {\\n    method: 'put',\\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication/MedicinalProductIndication-example',\\n    headers: { \\n        'Content-Type': 'application/fhir+json'\\n    },\\n    data: data\\n};\\n\\naxios(config)\\n.then(function (response) {\\n    console.log(JSON.stringify(response.data));\\n})\\n.catch(function (error) {\\n    console.log(error);\\n});\",\"label\":\"javascript Axios\"}]}},\"/fhir/MedicinalProductIndication/\":{\"get\":{\"operationId\":\"search-typeMedicinalProductIndication\",\"tags\":[\"MedicinalProductIndication\"],\"summary\":\"search-type MedicinalProductIndication resource by id.\",\"parameters\":[{\"name\":\"subject\",\"in\":\"query\",\"required\":false,\"schema\":{\"type\":\"string\"},\"description\":\"The medication for which this is an indication\"}],\"responses\":{\"200\":{\"description\":\"successful operation\",\"content\":{\"application/fhir+json\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"}},\"examples\":{\"Success-Response\":{\"value\":{\"resourceType\":\"Bundle\",\"type\":\"searchset\",\"total\":1,\"link\":[{\"relation\":\"self\",\"url\":\"http://burni.example.com/fhir/MedicinalProductIndication?_offset=0\u0026_count=100\"}],\"entry\":[{\"fullUrl\":\"http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827\",\"resource\":{\"resourceType\":\"MedicinalProductIndication\",\"id\":\"61904286-cdc0-4700-9c7a-d5f3d9bad827\",\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":18,\"unit\":\"a\"}}}],\"meta\":{\"tag\":[{\"system\":\"http://terminology.hl7.org/CodeSystem/v3-ActReason\",\"code\":\"HTEST\",\"display\":\"test health data\"}],\"versionId\":\"1\",\"lastUpdated\":\"2022-02-13T22:30:17.924+08:00\"}}}]}},\"No-Match\":{\"value\":{\"resourceType\":\"Bundle\",\"type\":\"searchset\",\"total\":0,\"link\":[{\"relation\":\"self\",\"url\":\"http://localhost:8090/fhir/Patient?name=1\u0026_offset=0\u0026_count=100\"}]}}}},\"application/fhir+xml\":{\"schema\":{\"type\":\"object\",\"items\":{\"$ref\":\"#/components/schemas/FHIR-XML-RESOURCE\"},\"xml\":{\"name\":\"Bundle\"}},\"examples\":{\"Success-Response-XML\":{\"value\":\"\u003c?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?\u003e\\n\u003cBundle xmlns=\\\"http://hl7.org/fhir\\\"\u003e\\n    \u003ctype value=\\\"searchset\\\"/\u003e\\n    \u003ctotal value=\\\"1\\\"/\u003e\\n    \u003clink\u003e\\n        \u003crelation value=\\\"self\\\"/\u003e\\n        \u003curl value=\\\"http://burni.example.com/fhir/MedicinalProductIndication?_offset=0\u0026amp;_count=100\\\"/\u003e\\n    \u003c/link\u003e\\n    \u003centry\u003e\\n        \u003cfullUrl value=\\\"http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827\\\"/\u003e\\n        \u003cresource\u003e\\n            \u003c?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?\u003e\u003cMedicinalProductIndication xmlns=\\\"http://hl7.org/fhir\\\"\u003e\u003cid value=\\\"80efee93-8d5a-4f98-aba7-ed1a8e88e0fc\\\"/\u003e\u003cmeta\u003e\u003cversionId value=\\\"1\\\"/\u003e\u003clastUpdated value=\\\"2022-02-17T17:34:54.818+08:00\\\"/\u003e\u003ctag\u003e\u003csystem value=\\\"http://terminology.hl7.org/CodeSystem/v3-ActReason\\\"/\u003e\u003ccode value=\\\"HTEST\\\"/\u003e\u003cdisplay value=\\\"test health data\\\"/\u003e\u003c/tag\u003e\u003c/meta\u003e\u003cdiseaseSymptomProcedure\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\\\"/\u003e\u003ccode value=\\\"Venousthromboembolismprophylaxis\\\"/\u003e\u003c/coding\u003e\u003ctext value=\\\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\\\"/\u003e\u003c/diseaseSymptomProcedure\u003e\u003ccomorbidity\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/comorbidity\\\"/\u003e\u003ccode value=\\\"Hipsurgery\\\"/\u003e\u003c/coding\u003e\u003c/comorbidity\u003e\u003cintendedEffect\u003e\u003ccoding\u003e\u003csystem value=\\\"http://ema.europa.eu/example/intendedeffect\\\"/\u003e\u003ccode value=\\\"PRYLX\\\"/\u003e\u003c/coding\u003e\u003c/intendedEffect\u003e\u003cpopulation\u003e\u003cageRange\u003e\u003clow\u003e\u003cvalue value=\\\"18\\\"/\u003e\u003cunit value=\\\"a\\\"/\u003e\u003c/low\u003e\u003c/ageRange\u003e\u003c/population\u003e\u003c/MedicinalProductIndication\u003e\\n        \u003c/resource\u003e\\n    \u003c/entry\u003e\\n\u003c/Bundle\u003e\"},\"No-Match\":{\"value\":\"\u003c?xml version=\\\"1.0\\\" encoding=\\\"UTF-8\\\"?\u003e\\n\u003cBundle xmlns=\\\"http://hl7.org/fhir\\\"\u003e\\n    \u003ctype value=\\\"searchset\\\"/\u003e\\n    \u003ctotal value=\\\"0\\\"/\u003e\\n    \u003clink\u003e\\n        \u003crelation value=\\\"self\\\"/\u003e\\n        \u003curl value=\\\"http://burni.example.com/fhir/MedicinalProductIndication?_offset=0\u0026amp;_count=100\\\"/\u003e\\n    \u003c/link\u003e\\n\u003c/Bundle\u003e\"}}}}}},\"x-codeSamples\":[{\"lang\":\"Shell\",\"source\":\"curl --location --request GET 'http://burni.example.com/fhir/MedicinalProductIndication'\",\"label\":\"cURL\"},{\"lang\":\"JavaScript\",\"source\":\"const axios = require('axios');\\nconst config = {\\n    method: 'get',\\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication'\\n};\\n\\naxios(config)\\n.then(function (response) {\\n    console.log(JSON.stringify(response.data));\\n})\\n.catch(function (error) {\\n    console.log(error);\\n});\",\"label\":\"javascript Axios\"}]}}},\"components\":{\"schemas\":{\"createMedicinalProductIndication\":{\"properties\":{\"resourceType\":{\"type\":\"string\",\"description\":\"\"}},\"required\":[\"resourceType\"]},\"FHIR-JSON-RESOURCE\":{\"properties\":{}},\"FHIR-XML-RESOURCE\":{\"properties\":{}},\"deleteMedicinalProductIndication\":{\"properties\":{\"id\":{\"type\":\"string\",\"description\":\"Resource ID in server\"}},\"required\":[\"id\"]},\"readMedicinalProductIndication\":{\"properties\":{\"id\":{\"type\":\"string\",\"description\":\"Resource ID in server\"}},\"required\":[\"id\"]},\"updateMedicinalProductIndication\":{\"properties\":{\"id\":{\"type\":\"string\",\"description\":\"Resource ID that you want to update\"},\"resourceType\":{\"type\":\"string\",\"description\":\"\"}},\"required\":[\"id\",\"resourceType\"]}}}}"
		}
	},
	"Error": "parse: parse spec: paths: /fhir/MedicinalProductIndication/: get: operation \"search-typeMedicinalProductIndication\": responses: 200: content: \"application/fhir+xml\": schema: parse schema: object cannot contain 'items' field"
}